1. Home
  2. CRI vs ALVO Comparison

CRI vs ALVO Comparison

Compare CRI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$38.42

Market Cap

1.2B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.57

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
ALVO
Founded
1865
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
CRI
ALVO
Price
$38.42
$3.57
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$35.60
$8.00
AVG Volume (30 Days)
1.2M
309.6K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
2.74%
N/A
EPS Growth
N/A
N/A
EPS
2.53
N/A
Revenue
$2,898,426,000.00
N/A
Revenue This Year
$4.57
$13.28
Revenue Next Year
$1.12
$18.63
P/E Ratio
$13.23
$18.20
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$3.03
52 Week High
$44.44
$11.85

Technical Indicators

Market Signals
Indicator
CRI
ALVO
Relative Strength Index (RSI) 57.77 51.68
Support Level $31.90 $3.03
Resistance Level $39.56 $3.93
Average True Range (ATR) 1.81 0.17
MACD -0.24 0.02
Stochastic Oscillator 69.37 61.22

Price Performance

Historical Comparison
CRI
ALVO

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: